<ѻý>Lambert-Eaton Myasthenic Syndrome Underdiagnosed Alongside SCLC in the U.S.ѻý> Findings suggest patients with SCLC are not screened for LEMS, despite their association Nov 02, 2023
<ѻý>ACS: Millions More Should Get Lung Cancer Screeningѻý> Notably, new recommendations say it doesn't matter when a person quit smoking Nov 01, 2023
<ѻý>Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPCѻý> Grade 3 or higher neutropenia, neutropenic complications reduced by 12-fold Nov 01, 2023
<ѻý>Potential Cure for Sickle Cell Clears Hurdle for Approvalѻý> FDA advisors suggest the benefits of gene therapy outweigh risks of off-target editing Oct 31, 2023
<ѻý>Personalized Intervention Helps CRC Screening Decisions for Older Adultsѻý> Patients receiving intervention were less likely to undergo screening if benefits were low Oct 31, 2023
<ѻý>The Exciting Potential of Antibody-Drug Conjugates in Lung Cancerѻý> Roy Herbst, MD, PhD, leads a discussion on ADCs targeting TROP2, HER2, and HER3 Oct 30, 2023 video
<ѻý>FDA Reviewers Question Safety of Sickle Cell Gene Therapyѻý> Efficacy results "strongly positive," but unintended off-target effects a question Oct 30, 2023
<ѻý>FDA OKs First Drug for Nasopharyngeal Carcinomaѻý> Toripalimab approved in combination with first-line chemo, and as monotherapy after progression Oct 30, 2023
<ѻý>Wegovy and Thyroid Cancer; Maine Shooter's Mental Health; 469 Heat Deathsѻý> Health news and commentary from around the Web gathered by ѻý staff Oct 30, 2023
<ѻý>Chinese Compound for MI?; Knee Pain Managementѻý> Also in TTHealthWatch: a new colorectal cancer screening test Oct 28, 2023 podcast
<ѻý>Soap to Fight Skin Cancer; $1,000 Early Cancer Detection Test; FDA Approval in MDSѻý> News, features, and commentary about cancer-related issues Oct 27, 2023
<ѻý>Neoadjuvant Cemiplimab Shows Potential as an Option for Cutaneous SCCѻý> Follow-up results from phase II study show 12-month EFS rate of 89% in stage II-IV disease Oct 25, 2023
<ѻý>Radionuclide Therapy Tops AR-Pathway Inhibitor Switch for mCRPCѻý> Time to radiographic progression doubled with 177Lu-PSMA-617 Oct 25, 2023
<ѻý>New Options Challenge Standard Treatments in EGFR-Mutant NSCLCѻý> Amivantamab-based regimens improved oncologic outcomes, but with more side effects Oct 25, 2023
<ѻý>Novel Stool RNA Test More Sensitive for Detecting Colon Cancer Versus FITѻý> ColoSense test outperforms fecal immunochemical testing in phase III trial Oct 25, 2023
<ѻý>ALK Inhibitor Outperforms Adjuvant Chemotherapy for Resected Lung Cancerѻý> Adjuvant alectinib reduces disease-free survival hazard by 76% Oct 24, 2023
<ѻý>Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancersѻý> Still some unanswered questions about benefit over other drug regimens, expert says Oct 24, 2023
<ѻý>Randomized Trial Backs HIF-2a Inhibition in Advanced RCCѻý> After immunotherapy-TKI failure, belzutifan produces better outcomes versus everolimus Oct 24, 2023
<ѻý>More Data Support Adding Immunotherapy to Chemo in Advanced Endometrial Cancerѻý> PFS doubled and OS improved, driven by mismatch repair-deficient disease Oct 23, 2023
<ѻý>Antibody-Drug Conjugate Boosts Survival in Recurrent/Metastatic Cervical Cancerѻý> Tisotumab vedotin reduced risk of death by 30% compared with chemotherapy Oct 23, 2023
<ѻý>Targeting KRAS in NSCLC: Recent Progress and New Approachesѻý> Roy Herbst, MD, PhD, leads a discussion on current and emerging treatments available Oct 23, 2023 video
<ѻý>Targeted Combination Wins in KRAS-Positive Metastatic Colorectal Cancerѻý> Standard dose of sotorasib plus panitumumab reduced risk of progression by 51% vs standard care Oct 23, 2023
<ѻý>Is It a Sports Injury, or Something More Serious?ѻý> Osteoscarcomas can present to any clinical setting, pediatric researcher says Oct 23, 2023
<ѻý>New First-Line Standard for Lung Cancers With EGFR Exon 20 Insertionsѻý> Adding amivantamab to chemotherapy improved PFS, induced more rapid and durable responses Oct 23, 2023
<ѻý>'Practice-Changing' Data in Locally Advanced Cervical Cancerѻý> Strategies involving immunotherapy, induction chemo move the needle for first time in decades Oct 23, 2023
<ѻý>RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLCѻý> Two randomized studies demonstrate significantly improved PFS against standard regimens Oct 22, 2023
<ѻý>Landmark Trial Produces New First-Line Standard for Advanced Bladder Cancerѻý> Enfortumab vedotin-pembrolizumab doubles OS, PFS versus chemotherapy Oct 22, 2023
<ѻý>Bi-Specific T-Cell Engager Active in Small-Cell Lung Cancer in Third Line and Beyondѻý> Tarlatamab achieves 40% overall response rate at the dose selected for continued evaluation Oct 22, 2023
<ѻý>Suzanne Somers' Legacy Tainted by Celebrity Medical Misinformationѻý> The actress harnessed the power of traditional media like social media influencers do today Oct 22, 2023
<ѻý>Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancerѻý> Durvalumab plus olaparib, or alone, paired with chemo boosts PFS in DUO-E trial Oct 21, 2023
<ѻý>Tebentafusp's OS Benefit in Uveal Melanoma Holds Up at 3 Yearsѻý> And early ctDNA reductions correlated with survival Oct 21, 2023
<ѻý>Carbohydrates and Long-Term Weight Change; Value of Cardiac Transfersѻý> Also in TTHealthWatch: reducing infections in joint replacement Oct 21, 2023 podcast
<ѻý>Pembrolizumab in First-Line Boosts PFS in HER2-Positive Stomach Cancerѻý> But label update planned after potential harm observed in PD-L1-negative subgroup Oct 20, 2023
<ѻý>Quad Regimen for High-Risk Myeloma Produces High Rates of Durable MRD Negativityѻý> Two-thirds of transplant-eligible patients met endpoint with isatuximab/KRd Oct 19, 2023
<ѻý>Lonely Cancer Deaths; Virtual Reality for Pain; 3D Models May Improve Treatmentѻý> News, features, and commentary about cancer-related issues Oct 19, 2023
<ѻý>Emicizumab Can Delay Immunosuppressive Tx in Acquired Hemophilia Aѻý> "Strategy will probably be practice-changing," says expert Oct 18, 2023
<ѻý>Senators Grill NIH Director Nominee on Drug Prices, Gender-Affirming Careѻý> Monica Bertagnolli, MD, makes her case during confirmation hearing Oct 18, 2023
<ѻý>Should Older Prostate Cancer Patients Jump Off the Active Surveillance Train?ѻý> It's time for clear guidelines Oct 18, 2023
<ѻý>What Caused the Pigmented Spot on Teen Boy's Eye?ѻý> Authors discuss how best to diagnose and manage him, given the absence of any symptoms Oct 17, 2023
<ѻý>Pembrolizumab Wins FDA Approval in Operable Lung Cancerѻý> Checkpoint inhibitor demonstrated significant survival improvement in perioperative setting Oct 17, 2023